Log in

OTCMKTS:GNWSFGeneNews Stock Price, Forecast & News

$0.07
0.00 (0.00 %)
(As of 05/25/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.07
Now: $0.07
$0.07
50-Day Range
$0.04
MA: $0.07
$0.10
52-Week Range
$0.02
Now: $0.07
$0.15
Volume25,400 shs
Average Volume39,742 shs
Market Capitalization$22.40 million
P/E RatioN/A
Dividend YieldN/A
Beta3.33
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GNWSF
CUSIPN/A
CIKN/A
Phone905-209-2030

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$190,000.00
Book Value($0.03) per share

Profitability

Net Income$-3,940,000.00
Net Margins-2,760.90%

Miscellaneous

Employees16
Market Cap$22.40 million
Next Earnings Date5/27/2020 (Estimated)
OptionableNot Optionable

Receive GNWSF News and Ratings via Email

Sign-up to receive the latest news and ratings for GNWSF and its competitors with MarketBeat's FREE daily newsletter.

GeneNews (OTCMKTS:GNWSF) Frequently Asked Questions

How has GeneNews' stock been impacted by COVID-19 (Coronavirus)?

GeneNews' stock was trading at $0.0266 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GNWSF stock has increased by 155.6% and is now trading at $0.0680. View which stocks have been most impacted by Coronavirus.

When is GeneNews' next earnings date?

GeneNews is scheduled to release its next quarterly earnings announcement on Wednesday, May 27th 2020. View our earnings forecast for GeneNews.

Has GeneNews been receiving favorable news coverage?

News articles about GNWSF stock have trended somewhat positive recently, InfoTrie reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. GeneNews earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the near term. View the latest news aboutGeneNews.

Who are some of GeneNews' key competitors?

Who are GeneNews' key executives?

GeneNews' management team includes the following people:
  • Mr. James R. Howard-Tripp, Exec. Chairman & CEO
  • Ms. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDL
  • Prof. Choong-Chin Liew Ph.D., Co-Founder
  • Mr. Warren Whitehead, Chief Accountant (Age 67)
  • Mr. David Suria, Sr. Scientist

What is GeneNews' stock symbol?

GeneNews trades on the OTCMKTS under the ticker symbol "GNWSF."

How do I buy shares of GeneNews?

Shares of GNWSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is GeneNews' stock price today?

One share of GNWSF stock can currently be purchased for approximately $0.07.

How big of a company is GeneNews?

GeneNews has a market capitalization of $22.40 million and generates $190,000.00 in revenue each year. GeneNews employs 16 workers across the globe.

What is GeneNews' official website?

The official website for GeneNews is www.genenews.com.

How can I contact GeneNews?

GeneNews' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at 905-209-2030 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.